Thiamidol® 630
Search documents
从ASPCR 2025看美白赛道趋势:优色林如何引领“色素元年”?
FBeauty未来迹· 2025-05-29 13:08
Core Viewpoint - The skincare industry is witnessing a transformation from emotional perception to scientific management, particularly in the realm of "whitening" products, with a focus on "pigment management" as a new paradigm [2][4]. Group 1: Scientific Advancements - Eucerin, a brand under Beiersdorf Group, showcased its "pigment management" concept at the 12th ASPCR conference, emphasizing the need for effective and evidence-based solutions for sensitive skin whitening [2][4]. - The Thiamidol® 630 ingredient, developed by Beiersdorf's research team, is highlighted as a revolutionary whitening agent, being the only one based on human tyrosinase screening and showing superior efficacy compared to existing whitening agents [5][7]. - Clinical trials have demonstrated that Thiamidol® 630 can significantly reduce skin pigmentation across all skin types, with over 110 clinical trials conducted in 28 countries involving approximately 8,500 participants [5][8]. Group 2: Market Impact - The second-generation Eucerin Brightening Essence, featuring Thiamidol® 630, received approval from the Chinese National Medical Products Administration in November 2024 and has since gained significant traction in the market, achieving over 131% growth in GMV on Douyin [7][21]. - The product has quickly become a top seller in major e-commerce platforms in China, indicating a successful transition from professional launch to widespread consumer acceptance [21][23]. Group 3: Consumer Engagement and Education - Eucerin's "Light Induction Workshop" at the ASPCR conference provided a comprehensive experience for consumers, combining professional insights with interactive activities to address skin concerns [12][14]. - The event featured personalized skin assessments and educational sessions, enhancing consumer understanding of sensitive skin management and the scientific basis of Eucerin's products [15][17]. - Feedback from participants indicates a shift in perception, with consumers recognizing the scientific foundation behind Eucerin's whitening solutions [17][19]. Group 4: Industry Evolution - The management of pigment disorders is evolving from confrontation to regulation, focusing on internal balance and personalized treatment plans, with Eucerin positioned as a leader in this transition [10][24]. - The brand's approach emphasizes a systematic methodology rather than merely marketing "sensitive skin" as a label, fostering trust and encouraging repeat purchases through scientific validation [24][25]. - The year 2025 is anticipated to be a landmark year for pigment management, marking a significant shift in the whitening industry towards comprehensive, gentle, and effective solutions [27][28].